Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone0114533444242
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.25 billion
Profitability
Miscellaneous
Employees5
Next Earnings DateN/A
OptionableNot Optionable
Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions
What is Forward Pharma A/S's stock symbol?
Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."
How were Forward Pharma A/S's earnings last quarter?
Forward Pharma A/S (NASDAQ:FWP) issued its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.
Has Forward Pharma A/S been receiving favorable news coverage?
News coverage about FWP stock has trended very negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Forward Pharma A/S earned a coverage optimism score of -3.1 on InfoTrie's scale. They also gave press coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Forward Pharma A/S.
Who are some of Forward Pharma A/S's key competitors?
Some companies that are related to Forward Pharma A/S include AcelRx Pharmaceuticals (ACRX), Mersana Therapeutics (MRSN), Chimerix (CMRX), Nature's Sunshine Products (NATR), Acer Therapeutics (ACER), LifeVantage (LFVN), Galectin Therapeutics (GALT), TAIWAN LIPOSOME/S (TLC), BioXcel Therapeutics (BTAI), Strongbridge Biopharma (SBBP), CytoDyn (CYDY), Minerva Neurosciences (NERV), Kezar Life Sciences (KZR), Millendo Therapeutics (MLND) and Newron Pharmaceuticals (NWPHF).
What other stocks do shareholders of Forward Pharma A/S own?
Who are Forward Pharma A/S's key executives?
Forward Pharma A/S's management team includes the folowing people:
- Mr. Florian Schonharting, Co-Founder & Chairman (Age 50)
- Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 42)
- Mr. Thomas Carbone, Principal Accounting Officer (Age 62)
How do I buy shares of Forward Pharma A/S?
Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Forward Pharma A/S's stock price today?
One share of FWP stock can currently be purchased for approximately $0.98.
How big of a company is Forward Pharma A/S?
What is Forward Pharma A/S's official website?
How can I contact Forward Pharma A/S?
Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]
MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
